| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8211161 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 23 Pages |
Abstract
The reported data of moderate hypofractionation are consistent with a low α/β value with narrow CIs. Dose-escalation trials have demonstrated a dose response for bNED. Escalating doses to >80 Gy EQD2 might not improve bNED. A correlation between benefit in bNED and OS was not found.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ivan R. PhD, DMSc, Søren M. PhD, DSc,